DK1179183T3 - Fremgangsmåde til identifikation af præneoplastiske og/eller neoplastiske tilstande hos pattedyr - Google Patents

Fremgangsmåde til identifikation af præneoplastiske og/eller neoplastiske tilstande hos pattedyr

Info

Publication number
DK1179183T3
DK1179183T3 DK00918600.8T DK00918600T DK1179183T3 DK 1179183 T3 DK1179183 T3 DK 1179183T3 DK 00918600 T DK00918600 T DK 00918600T DK 1179183 T3 DK1179183 T3 DK 1179183T3
Authority
DK
Denmark
Prior art keywords
neoplastic
mammals
identifying pre
conditions
identifying
Prior art date
Application number
DK00918600.8T
Other languages
English (en)
Inventor
Michael Slater
Julian Barden
Original Assignee
Biosceptre Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosceptre Int Ltd filed Critical Biosceptre Int Ltd
Application granted granted Critical
Publication of DK1179183T3 publication Critical patent/DK1179183T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
DK00918600.8T 1999-04-21 2000-04-26 Fremgangsmåde til identifikation af præneoplastiske og/eller neoplastiske tilstande hos pattedyr DK1179183T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP9911A AUPP991199A0 (en) 1999-04-21 1999-04-21 Methods for diagnosing pre-cancerous and cancerous conditions
PCT/AU2000/000363 WO2001006259A1 (en) 1999-04-21 2000-04-26 A method for identifying pre-neoplastic and/or neoplastic states in mammals

Publications (1)

Publication Number Publication Date
DK1179183T3 true DK1179183T3 (da) 2010-05-25

Family

ID=3814111

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00918600.8T DK1179183T3 (da) 1999-04-21 2000-04-26 Fremgangsmåde til identifikation af præneoplastiske og/eller neoplastiske tilstande hos pattedyr

Country Status (15)

Country Link
US (3) US7183064B1 (da)
EP (1) EP1179183B1 (da)
JP (1) JP4633984B2 (da)
KR (1) KR100819395B1 (da)
CN (1) CN100557445C (da)
AT (1) ATE456799T1 (da)
AU (2) AUPP991199A0 (da)
CA (1) CA2371163A1 (da)
DE (1) DE60043775D1 (da)
DK (1) DK1179183T3 (da)
ES (1) ES2340137T3 (da)
HK (1) HK1044190A1 (da)
NO (1) NO331018B1 (da)
WO (1) WO2001006259A1 (da)
ZA (1) ZA200108616B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP991199A0 (en) * 1999-04-21 1999-05-13 University Of Sydney, The Methods for diagnosing pre-cancerous and cancerous conditions
AUPR201500A0 (en) * 2000-12-11 2001-01-11 Biosceptre Pty Ltd Methods for identifying pre-neoplastic and neoplastic states in mammals
TWI319011B (en) * 2001-01-17 2010-01-01 Intreat Pty Ltd Diagnosis and treatment of cancers and other conditions
AU2007306924A1 (en) 2006-10-10 2008-04-17 Biosceptre International Limited Hybridomas producing antibodies against non functional P2X7 receptor
AU2013238152B2 (en) * 2007-09-14 2015-09-24 Biosceptre International Limited Purinergic (P2X) receptors in extra-cellular body fluid
WO2009033233A1 (en) 2007-09-14 2009-03-19 Biosceptre International Limited Novel p2x7 epitopes
WO2009033234A1 (en) * 2007-09-14 2009-03-19 Biosceptre International Limited Purinergic (p2x) receptors in extra-cellular body fluid
CN102143978B (zh) 2008-07-04 2015-02-18 生物权威国际有限公司 抗p2x7肽和表位
CN107011434B (zh) * 2008-12-19 2021-02-19 埃博灵克斯股份有限公司 用于产生针对细胞相关抗原如p2x7、cxcr7或cxcr4的免疫球蛋白的基因免疫
EP2966090B1 (en) 2009-08-20 2018-10-10 Biosceptre (Aust) Pty Ltd Anti p2x7 receptor antibodies and fragments thereof
CA2784345C (en) 2009-12-24 2018-11-13 Julian Alexander Barden Antibodies to non-functional oligomeric p2x7 receptors
ES2656971T3 (es) 2010-09-10 2018-03-01 Biosceptre (Aust) Pty Ltd Tratamientos para el cáncer en animales de compañía con un anticuerpo anti P2X7
ES2689272T3 (es) 2011-07-01 2018-11-13 Biosceptre (Aust) Pty Ltd Terapia de combinación
US10654926B2 (en) * 2014-05-02 2020-05-19 Medimmune Limited P2X4 antibodies and uses thereof
MX2019004410A (es) 2016-10-21 2019-09-26 Biosceptre Uk Ltd Particulas citotoxicas.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE920765A1 (en) * 1991-03-12 1992-09-23 Scripps Research Inst Cell surface receptors homologous to coagulation factors v¹and viii
JP3084982B2 (ja) * 1992-11-25 2000-09-04 富士電機株式会社 半導体装置
JPH10501122A (ja) * 1994-05-27 1998-02-03 グラクソ、グループ、リミテッド Ｐ▲下２ｘ▼レセプター（プリノセプターファミリー）
EP0854923A2 (en) * 1995-08-09 1998-07-29 Institut National De La Sante Et De La Recherche Medicale (Inserm) Isolated nucleic acid molecules useful as leukemia markers and in breast cancer prognosis
EP0907729A1 (en) * 1996-04-30 1999-04-14 Smithkline Beecham Plc HUMAN P2x4 RECEPTOR SPLICE-VARIANTS
US6303338B1 (en) * 1996-08-16 2001-10-16 Human Genome Sciences, Inc. Pancreas-derived plasminogen activator inhibitor
JP3885177B2 (ja) 1997-03-26 2007-02-21 大塚製薬株式会社 ヒト遺伝子
US6133434A (en) * 1997-04-28 2000-10-17 Glaxo Group Limited Purinergic receptor
DE19829473C2 (de) * 1998-07-01 2000-08-10 Magnus Von Knebel Doeberitz Ch Verfahren zur frühen Diagnose von Carcinomen
AUPP991199A0 (en) * 1999-04-21 1999-05-13 University Of Sydney, The Methods for diagnosing pre-cancerous and cancerous conditions
AUPR201500A0 (en) * 2000-12-11 2001-01-11 Biosceptre Pty Ltd Methods for identifying pre-neoplastic and neoplastic states in mammals
TWI319011B (en) * 2001-01-17 2010-01-01 Intreat Pty Ltd Diagnosis and treatment of cancers and other conditions

Also Published As

Publication number Publication date
KR20020022651A (ko) 2002-03-27
EP1179183A1 (en) 2002-02-13
CN1355886A (zh) 2002-06-26
US7183064B1 (en) 2007-02-27
KR100819395B1 (ko) 2008-04-04
ATE456799T1 (de) 2010-02-15
CA2371163A1 (en) 2001-01-25
NO20015157D0 (no) 2001-10-22
US20070248963A1 (en) 2007-10-25
JP4633984B2 (ja) 2011-02-16
NO331018B1 (no) 2011-09-12
ZA200108616B (en) 2002-06-13
JP2003504643A (ja) 2003-02-04
DE60043775D1 (de) 2010-03-18
NO20015157L (no) 2001-12-21
WO2001006259A1 (en) 2001-01-25
ES2340137T3 (es) 2010-05-31
US20110111431A1 (en) 2011-05-12
CN100557445C (zh) 2009-11-04
HK1044190A1 (en) 2002-10-11
EP1179183A4 (en) 2003-01-22
AU3949000A (en) 2001-02-05
AU779845B2 (en) 2005-02-17
AUPP991199A0 (en) 1999-05-13
EP1179183B1 (en) 2010-01-27

Similar Documents

Publication Publication Date Title
DK1179183T3 (da) Fremgangsmåde til identifikation af præneoplastiske og/eller neoplastiske tilstande hos pattedyr
DK1137798T3 (da) Fremgangsmåde til isolering af stamceller
DK1290444T3 (da) Toxicitetstypisering under anvendelse af lever-stamceller
NO20065084L (no) Interferon-alfa polypeptider og konjugater
NO20052363L (no) Interferon-alfa polypeptider og konjugater
DE69909987D1 (de) Sputtertarget, transparenter leitender film und verfahren zu dessen herstellung
DE60038306D1 (de) Differentialdruckströmungsmesser mit integrierten druckanschlüssen
DE60112173D1 (de) Herstellungsverfahren für abzweigenden Stent mit verbesserter Nebenöffnung
RS51903B (sr) Formulacija aripiprazol kompleksa i postupak
WO2003014303A3 (en) Molecular interactions in cells
DE60138415D1 (de) Expression von p2y-purinergem rezeptor zur identifizierung präneoplastischer und neoplastischer zustände
DE69900738D1 (de) Kraftstoff-servicer
BR9703386A (pt) Células aviárias imortalizadas
DK1109879T3 (da) Fremgangsmåde til reducering af totalsyretallet i råolie
NO981818D0 (no) FremgangsmÕte for Õ mobilisere hematopoetiske stamceller
ATE309140T1 (de) Behälterbausatz
PT1127133E (pt) Polipeptido que proporciona permeabilidade celular
WO2001094573A3 (en) Processing of plasmid-containing fluids
SE0201750D0 (sv) Selective Chromophores
ATE267206T1 (de) 5-imino-13-deoxy-antracyclin-derivate, ihre verwendung sowie verfahren zu deren herstellung
DE29510768U1 (de) Überschieb-Muffe mit Rohrschelle o.dgl. für Rohrverbindungen oder -anschlüsse
DE29609653U1 (de) Rechenschieber für Druckverlustberechnung von in Rohren strömenden Gasen im Niederdruckbereich
FR2717606B1 (fr) Echantillonneur-bloqueur différentiel rapide.
ATA2802000A (de) Vakummdichtes gehäusesystem für zweipolige bauelemente und verfahren zu dessen herstellung
DK1301795T3 (da) Fremgangsmåde til identificering og/eller isolering af stamceller